Continuing review of an approved and ongoing study posing more than minimal risk that was initially approved by a convened irb:
a. must be conducted by a convened irb. b. is limited to review of unanticipated problems. c. must occur within 12 months of the approval date. d. is not required unless additional risks have been identified.

Continuing review of an approved and ongoing study posing more than minimal risk that was initially approved by a convened IRB: Must occur within 12 months of the approval date.

Explanation:

The Institutional Review Board (IRB) is an administrative body set up to protect the interests and well-being of individuals involved in research, appointed below the auspices for the organization it is associated with.

Approval for experiments involving minimum risk is relevant for even more than one year.

IRB exercises its authority to determine the length of its approval for non-minimal risk analysis, which can be less than one year.

answer; larger numbers of minority;